Ur-Kare 'N' Cure Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2010.

2010 Mumbai, Maharashtra, India Struck Off

Last Updated: July 24, 2025

About Ur-Kare 'N' Cure Pharmaceuticals Private Limited

Ur-Kare 'N' Cure Pharmaceuticals Private Limited, a struck off private limited company, was established on 30 December 2010 in Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2010PTC211621. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Prithviraj Jagdishprasad Koli (Director), Yash Dhirajlal Shah (Director). It is based at Jagdish House, Pascal Wadi Madh Island, Malad (West), Mumbai, Maharashtra, 400061.

Company Details

CIN/LLPIN
U24100MH2010PTC211621
Registration Number
211621
Incorporation Date
30 December 2010
Authorized Capital
₹0.10 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.10 M as on 24-07-2025
Paid Up Capital ₹ 0.10 M as on 24-07-2025
Company Age 15 Year, 1 Month

Comprehensive Company Insights

Explore comprehensive insights into Ur-Kare 'N' Cure Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ur-Kare 'N' Cure Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Prithviraj Jagdishprasad Koli	Director	30 Dec 2010	Current
Yash Dhirajlal Shah	Director	30 Dec 2010	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ur-Kare 'N' Cure Pharmaceuticals.

Enhance accessibility to Ur-Kare 'N' Cure Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ur-Kare 'N' Cure Pharmaceuticals?

Unlock access to Ur-Kare 'N' Cure Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ur-Kare 'N' Cure Pharmaceuticals?

Unlock and access historical data on people associated with Ur-Kare 'N' Cure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ur-Kare 'N' Cure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ur-Kare 'N' Cure Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ur-Kare 'N' Cure Pharmaceuticals

Recent Activity within the Organization

Director Appointment

Prithviraj Jagdishprasad Koli was appointed as a Director was appointed as a Director on 30 Dec 2010 & has been associated with this company since 15 years 1 month . was recorded as a recent event.
30 Dec 2010
Director Appointment

Yash Dhirajlal Shah was appointed as a Director was appointed as a Director on 30 Dec 2010 & has been associated with this company since 15 years 1 month . was recorded as a recent event.
30 Dec 2010
Company Incorporation

The activity Ur-Kare 'N' Cure Pharmaceuticals Private Limited was registered on 30 Dec 2010 with Roc Mumbai & aged 15 years 1 month as per MCA records. was completed.
30 Dec 2010

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Ur-Kare 'N' Cure Pharmaceuticals Private Limited?

The CIN of Ur-Kare 'N' Cure Pharmaceuticals Private Limited is U24100MH2010PTC211621.

Where is Ur-Kare 'N' Cure Pharmaceuticals Private Limited headquartered?

Ur-Kare 'N' Cure Pharmaceuticals Private Limited is headquartered at Jagdish House, Pascal Wadi Madh Island, Malad (West), Mumbai, Maharashtra, 400061.

When was Ur-Kare 'N' Cure Pharmaceuticals Private Limited incorporated?

Ur-Kare 'N' Cure Pharmaceuticals Private Limited was incorporated on 30 December 2010.

Who are the current directors of Ur-Kare 'N' Cure Pharmaceuticals Private Limited?

The current directors of Ur-Kare 'N' Cure Pharmaceuticals Private Limited are

What is the primary industry of Ur-Kare 'N' Cure Pharmaceuticals Private Limited?

The primary industry of Ur-Kare 'N' Cure Pharmaceuticals Private Limited is Chemicals.

Is Ur-Kare 'N' Cure Pharmaceuticals Private Limited a listed company?

Ur-Kare 'N' Cure Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ur-Kare 'N' Cure Pharmaceuticals Private Limited?

The authorized capital of Ur-Kare 'N' Cure Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available